These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1803228)

  • 1. Morphological changes of Candida albicans induced by saperconazole.
    Montès B; Mallié M; Jouvert S; Bastide JM
    Mycoses; 1991; 34(7-8):287-92. PubMed ID: 1803228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of saperconazole on the morphology of Candida albicans, Pityrosporum ovale and Trichophyton rubrum in vitro.
    Jansen T; Borgers M; van de Ven MA; Xhonneux B; Wouters L; van Gerven F; van Cutsem J
    J Med Vet Mycol; 1991; 29(5):293-303. PubMed ID: 1955949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis.
    Mallié M; Montès B; Lebecq JC; Bastide JM
    Mycoses; 1989 Dec; 32(12):631-7. PubMed ID: 2695841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study of in vitro antibiotic activity of saperconazole and other azoles on Paracoccidioides brasiliensis.
    San-Blas G; Calcagno AM; San-Blas F
    J Med Vet Mycol; 1993; 31(2):169-74. PubMed ID: 8389848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy.
    Drouhet E; Dupont B; Improvisi L; Lesourd M; Prevost MC
    J Med Vet Mycol; 1990; 28(6):425-36. PubMed ID: 2093115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural alterations of Candida albicans induced by a new imidazole antimycotic omoconazole nitrate.
    Nishiyama Y; Itoyama T; Yamaguchi H
    Microbiol Immunol; 1997; 41(5):395-402. PubMed ID: 9194038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saperconazole: a selective inhibitor of the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes.
    Vanden Bossche H; Marichal P; Willemsens G; Bellens D; Gorrens J; Roels I; Coene MC; Le Jeune L; Janssen PA
    Mycoses; 1990; 33(7-8):335-52. PubMed ID: 2090934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saperconazole: in vitro and in vivo anticandidal activity.
    Fu KP; Isaacson D; Foleno B; LoCoco J
    Chemotherapy; 1992; 38(3):174-8. PubMed ID: 1511634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations produced by sertaconazole on the morphology and ultrastructure of Candida albicans.
    Guarro J; Figueras MJ; Cano J
    Mycoses; 1989 Jun; 32(6):283-95. PubMed ID: 2674712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in surface morphology of Candida albicans produced by rilopirox: a scanning electron microscopy study.
    Braga PC; Maci S; Dal Sasso M; Piatti G; Bohn M
    J Chemother; 1995 Dec; 7(6):519-24. PubMed ID: 8667036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural degeneration of Aspergillus fumigatus after exposure to saperconazole.
    Borgers M; Van de Ven MA; Van Cutsem J
    J Med Vet Mycol; 1989; 27(6):381-9. PubMed ID: 2697753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of isoconazole on Candida albicans. Study by scanning and transmission electron microscopy].
    Moulin-Traffort J; Venot C; Regli P
    Pathol Biol (Paris); 1986 Oct; 34(8):899-907. PubMed ID: 3537934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activity of saperconazole (R 66 905) in vitro.
    Odds FC
    J Antimicrob Chemother; 1989 Oct; 24(4):533-7. PubMed ID: 2613602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological changes of Candida albicans induced by BMY-28864, a highly water-soluble pradimicin derivative.
    Numata K; Ueki T; Naito N; Yamada N; Kamasawa N; Oki T; Osumi M
    J Electron Microsc (Tokyo); 1993 Jun; 42(3):147-55. PubMed ID: 8376921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal action of latex saps from Lactuca sativa L. and Asclepias curassavica L.
    Moulin-Traffort J; Giordani R; Régli P
    Mycoses; 1990; 33(7-8):383-92. PubMed ID: 2090937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans.
    Endo EH; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
    Res Microbiol; 2010 Sep; 161(7):534-40. PubMed ID: 20541606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new pyrazolo [3, 4-d]pyrimidine on growth and morphology of Candida albicans.
    Califano A; Poli T; Vannini GL
    Mycopathologia; 1986 Mar; 93(3):189-92. PubMed ID: 3520331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the action of alpha-hederin on the ultrastructure of Candida albicans.
    Moulin-Traffort J; Favel A; Elias R; Regli P
    Mycoses; 1998 Nov; 41(9-10):411-6. PubMed ID: 9916465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of aculeacin A and papulacandin B on morphology and cell wall ultrastructure in Candida albicans.
    Bozzola JJ; Mehta RJ; Nisbet LJ; Valenta JR
    Can J Microbiol; 1984 Jun; 30(6):857-63. PubMed ID: 6386132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microscopic studies of Candida albicans and Torulopsis glabrata after in vitro treatment with bifonazole. Freeze fracture electron microscopy.
    Barug D; de Groot C
    Arzneimittelforschung; 1983; 33(4):538-45. PubMed ID: 6347210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.